A real value of BIT 225 is if being able to piggy-back for such effect in specific problems, like it does for HIV, means that it may have similar values in expeditious treatment associated with many difficult disorders and disease where no rapid effect or vaccination has been found. Further if the BIT compound action as an adjuvent is shown to have no harmful side effect itself, it is potentially going to be rapidly trialed as a booster for treatment supplementation in many treatment compounds, sooner rather than via current long trial times.
Ann: BIT225 RESTORES IMMUNE FUNCTION IN HIV-1 INFECTIONS, page-207
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.001(1.92%) |
Mkt cap ! $46.91M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.1¢ | $16.61K | 321.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11759 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 76926 | 1 |
View Market Depth
| Last trade - 15.52pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
-0.001 ( 3.70 %) |
||||
| Open | High | Low | Volume | ||
| 5.2¢ | 5.5¢ | 5.1¢ | 198569 | ||
| Last updated 15.59pm 22/05/2024 ? | |||||
| BIT (ASX) Chart |